At the recent Honeywell Users Group (HUG) in Phoenix, experts from Merck, Abbott and Genentech shared lessons learned in key automation and control projects. Merck in Rahway has upgraded its process control system, while Abbott and Genentech are exploring the boundaries of manufacturing execution systems (MES).
To read presentation summaries, follow the links below:
To hear podcast interviews, follow these links:
- Chris Schreil, Genentech's senior manager for automation engineering at its CCP2 (second cell culture plant) facility in Vacaville, Calif., talks about the new plant's hybrid control and automation architecture.
- Steve Zarichniak, Honeywell applications consultant, discusses his company's manufacturing control solution for pharmaceutical facilities.